Acute mastoiditis in children during the Covid era: A systematic review and meta-analysis

Erin E Briggs1, Isabelle J Chau2, Shaun A Nguyen3

  • 1Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, 135 Rutledge Ave, MSC 550, Charleston, SC, 29425, USA; Thomas Jefferson University School of Medicine, Philadelphia, PA, USA.

Insights

The COVID-19 pandemic increased intracranial complications in pediatric acute mastoiditis (AM). Fewer AM cases were treated with antibiotics alone, and bacterial patterns shifted, requiring new management strategies.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Pediatric Health

Background:

  • Pediatric acute mastoiditis (AM) is a significant concern.
  • The COVID-19 pandemic may have influenced AM presentation and management.
  • Understanding these changes is crucial for optimal pediatric care.

Purpose of the Study:

  • To investigate the impact of the COVID-19 pandemic on pediatric acute mastoiditis.
  • To analyze changes in clinical presentation, bacterial epidemiology, complications, and management of AM during the pandemic.

Main Methods:

  • A systematic literature search was conducted across major databases (CINAHL, Cochrane Library, PubMed, Scopus).
  • Studies published between 2014 and 2025 reporting on pediatric AM were included.
  • Outcomes assessed included clinical presentation, bacterial epidemiology, complications, and treatment, with statistical analysis of proportions and risks.

Main Results:

  • Seven studies (N=1001 children) were analyzed, comparing pre-COVID and COVID-era cohorts.
  • A significant increase in intracranial complications was observed post-pandemic (RR: 1.2).
  • Conservative antibiotic treatment decreased significantly (mean difference 10.8%), and bacterial epidemiology shifted.

Conclusions:

  • The COVID-19 pandemic is associated with increased intracranial complications in pediatric AM.
  • Fewer cases are managed solely with antibiotics, and bacterial patterns have changed.
  • Further research is needed to adapt AM management strategies in the post-pandemic era.
Abstract

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
396
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
1.8K
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
3.8K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
308
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
751
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
210